Case report reveals diagnostic challenges and palliative treatment options for gastric squamous cell carcinoma in an elderly female, indicating the need for better sampling practices.
Objective To report the diagnosis and treatment of a rare case of primary gastric squamous cell carcinoma (PGSCC) in an elderly female, and to explore the diagnostic pitfalls and individualized treatment strategies. Methods We conducted a retrospective analysis of the clinical, imaging, endoscopic, and pathological data of a 77-year-old female patient. The evolution of the diagnosis from the initial “possible adenocarcinoma” to the final diagnosis of “ squamous cell carcinoma” was emphasized. Results The patient presented with abdominal pain. The first endoscopic biopsy, due to the limited tissue sample, showed immunohistochemistry results of CKpan (+), CK7(+), MUC5AC (focal+), and Ki-67(partly+), favoring a diagnosis of adenocarcinoma. A subsequent deep biopsy with complete immunohistochemistry (CK5/6+, P40+, P63+) confirmed the diagnosis of gastric squamous cell carcinoma. Given the patient’s advanced age, poor physical condition, and refusal of surgery, a palliative treatment plan of “Raltitrexed + Sintilimab” was finally decided upon after a multidisciplinary consultation. Conclusion This case highlights the importance of adequate sampling in the diagnosis of gastric squamous cell carcinoma to avoid misdiagnosis due to limited specimens. It also provides a potential treatment option of immune therapy combined with low-dose chemotherapy for elderly patients with gastric squamous cell carcinoma who are not suitable for surgery.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: